Difference between revisions of "Tuberculosis"

(Latent TB)
 
(33 intermediate revisions by 9 users not shown)
Line 1: Line 1:
 
==Background==
 
==Background==
[[File:MiliaryTB.png|thumb|Miliary TB neonate born to mother with active TB]]
+
*Over 1/3 of world's population is infected
*>1/3 of world's population is infected[[File:Tuberculosis-x-ray-1.jpg|thumbnail|Bilateral pulmonary tuberculosis]]
 
  
 
===Infection Types===
 
===Infection Types===
 
*Primary Infection
 
*Primary Infection
 
**Usually contained by body via formation of tubercles
 
**Usually contained by body via formation of tubercles
**Hematogenous spread limited to areas w/ high O2 or blood flow (apical lung, vertebrae)
+
**Hematogenous spread limited to areas with high O2 or blood flow (apical lung, vertebrae)
 
***PPD positive
 
***PPD positive
 
*Reactivation Infection
 
*Reactivation Infection
**More common in immunocompromised pts (AIDS, malignancy, DM, CRF)
+
**More common in immunocompromised patients (AIDS, malignancy, DM, immunosupressive medications)
*Check HIV in pts suspected of TB
+
*Miliary Tuberculosis
 +
**Disseminated tuberculosis
 +
**Looks like millet seeds
 +
**Seen in patients with comorbid AIDS
 +
***Check [[HIV]] in patients suspected of TB
 +
**PPD is positive in only 50% of cases
  
 
===Special Populations===
 
===Special Populations===
Line 18: Line 22:
 
***Increased risk when <500
 
***Increased risk when <500
 
***Determines the clinical and radiographic presentations of TB
 
***Determines the clinical and radiographic presentations of TB
*Peds
+
*Pediatric
 
**More likely to progress early to active disease
 
**More likely to progress early to active disease
 
***Presentation more commonly that of primary TB
 
***Presentation more commonly that of primary TB
 
**>5yr - classic symptoms
 
**>5yr - classic symptoms
**<5yr - miliary TB, meningitis, cervical lymphadenitis, PNA that doesn't respond to abx
+
**<5yr - miliary TB, [[meningitis]], [[scrofula|cervical lymphadenitis]], [[pneumonia]] that does not respond to usual antibiotics
 
**Children are usually not infectious due to their weak cough
 
**Children are usually not infectious due to their weak cough
 +
 +
===Tuberculin Skin Test===
 +
;Used for population screening, but not for rule-out in patients with concern for active disease
 +
''Reaction considered positive in following situations:''
 +
*>5 mm
 +
**[[HIV]] positive
 +
**Close contact with active TB patient
 +
**Nodular or fibrotic changes on CXR
 +
**Immunosuppressed (TNF-alpha inhibitor, chemo, organ transplant)
 +
*>10 mm
 +
**Children < 4 yrs old
 +
**Healthcare/lab/prison employees and residents
 +
**Co-morbid conditions (dialysis, DM, blood/head/neck/lung malignancy, IV drug users)
 +
**People from high prevalence areas
 +
*>15 mm
 +
**Persons with no known risk factors for TB
  
 
==Clinical Features==
 
==Clinical Features==
 +
[[File:Screen Shot 2015-09-11 at 9.27.22 AM.png|thumbnail|Tuberculous lymphadenopathy]]
 
===Primary Tuberculosis===
 
===Primary Tuberculosis===
*Usually asymptomatic (only identified by positive PPD)[[File:Screen Shot 2015-09-11 at 9.27.22 AM.png|thumbnail|Tuberculous lymphadenopathy]][[File:Screen Shot 2015-09-11 at 9.21.17 AM.png|thumbnail|Tuberculous vertebral osteomyelitis (Pott's Disease)]]
+
*Usually asymptomatic (only identified by positive PPD/quantiferon gold)
*May be rapidly progressive and fatal in immunocompromised pts
+
*May be rapidly progressive and fatal in immunocompromised patients
**Fever, malaise, wt loss, chest pain
+
**[[Fever]], malaise, weight loss, [[chest pain]]
*Tuberculous pleural effusion may occur if subpleural node ruptures into the pleura
+
*Tuberculous [[pleural effusion]] may occur if subpleural node ruptures into the pleura
**Pleuritic chest pain
+
**Pleuritic [[chest pain]]
 
**Exudative fluid
 
**Exudative fluid
 
***Organisms may not be visible on acid-fast staining (need pleural biopsy)
 
***Organisms may not be visible on acid-fast staining (need pleural biopsy)
 +
 
===Reactivation Tuberculosis===
 
===Reactivation Tuberculosis===
*Pulmonary: Productive cough, hemoptysis, dyspnea, pleuritic chest pain
+
*Pulmonary: Productive [[cough]], [[hemoptysis]], [[dyspnea]], pleuritic [[chest pain]]
*Systemic: Fever, night sweats, malaise, fatigue, wt loss
+
*Systemic: [[Fever]], night sweats, malaise, fatigue, weight loss
 
*Extrapulmonary  
 
*Extrapulmonary  
**Painless lymphadenopathy (most common extrapulmonary manifestation)
+
**Painless lymphadenopathy/[[scrofula]] (most common extrapulmonary manifestation)
**Pericarditis
+
**[[Pericarditis]]
**Peritonitis  
+
**[[Peritonitis]]
**Meningitis
+
**[[Meningitis]]
**Adrenal insufficiency
+
**[[Adrenal insufficiency]]
**Arthritis
+
***If adrenals affected, TB typically spreads to bilateral adrenals rather than unilateral
**Osteomyelitis
+
***Think about in the patient presenting in shock with TB risk factors
 +
**[[Arthritis]]
 +
**[[Osteomyelitis]]
 +
***Pott's disease, usually in thoracic spine
  
 
==Differential Diagnosis==
 
==Differential Diagnosis==
 
{{HIV associated conditions}}
 
{{HIV associated conditions}}
  
==Diagnosis==
+
==Evaluation==
===CXR===
+
[[File:Miliary.png|thumbnail|CXR of miliary TB]]
 +
[[File:MiliaryTB.png|thumb|Miliary TB neonate born to mother with active TB]]
 +
[[File:Tuberculosis-x-ray-1.jpg|thumbnail|Bilateral pulmonary tuberculosis]]
 +
[[File:Screen Shot 2015-09-11 at 9.21.17 AM.png|thumbnail|Tuberculous vertebral osteomyelitis (Pott's Disease)]]
 +
===[[CXR]]===
 
*Primary infection
 
*Primary infection
 
**Infiltrates in any area of the lung
 
**Infiltrates in any area of the lung
Line 59: Line 88:
 
**Upper lobe or hilar nodules and fibrotic lesions
 
**Upper lobe or hilar nodules and fibrotic lesions
 
**Ghon foci, areas of scarring, calcification
 
**Ghon foci, areas of scarring, calcification
*HIV pts less likely to have classic lesions and may have normal CXR
+
*Miliary TB
 +
**Looks like millet seeds on CXR
 +
*Immunocompromised patients less likely to have classic lesions and may have normal CXR
 +
 
 +
===PCR Sputum Assay===
 +
*Rapidly detects TB in sputum specimens (as well as [[rifampin]] resistance)
 +
*Use to rule-out patients for active TB
 +
*Need two sputum specimens (expectorated or induced) at least 8 hours apart (including at least one early morning specimen)
  
==Treatment==
+
==Management==
 
===Active TB===
 
===Active TB===
*Isoniazid + rifampin + pyrazinamide + ethambutol x8wk followed by INH/RIF x18wk
+
*[[Isoniazid]] + [[rifampin]] + [[pyrazinamide]] + [[ethambutol]] x 8wk followed by INH/rifampin x18wk
**2 drug continuation tx x 18-31wk
+
**2 drug continuation treatment x 18-31wk
 
===Latent TB===
 
===Latent TB===
 +
*Isoniazid x 9 months
 
*Consider treatment for:
 
*Consider treatment for:
 
**Recent conversion to PPD-positive
 
**Recent conversion to PPD-positive
**Persons in close contact w/ individual w/ active TB
+
**close contact with active TB
**Isoniazid x9mo
+
**immunocompromised patients (or plan to start immunosuppressive medications)
 +
*New vaccine has demonstrated effectiveness (50%) in preventing progression to active TB<ref>Final analysis of a trial of M72/AS01E vaccine to prevent tuberculosis Tait DR, Hatherill M, Van Der Meeren O, et al. N Engl J Med. 2019;381(25):2429-2439.</ref>. However, this is not yet widely available and further research is needed.
  
 
==Disposition==
 
==Disposition==
Line 75: Line 113:
 
*Otherwise healthy
 
*Otherwise healthy
 
**Contact public health services before discharge
 
**Contact public health services before discharge
***Instructions for home isolation and f/u at appropriate clinic to receive meds
+
***Instructions for home isolation and follow up at appropriate clinic to receive meds
 
**Do not start TB meds in ED unless specifically instructed by public health
 
**Do not start TB meds in ED unless specifically instructed by public health
  
Line 81: Line 119:
 
*Ill-appearing
 
*Ill-appearing
 
*Diagnosis is uncertain
 
*Diagnosis is uncertain
*Pt is noncompliant
+
*Patient is treatment non-adherent
  
 
==References==
 
==References==
*Tintinalli
+
<references/>
 
[[Category:ID]]
 
[[Category:ID]]
[[Category:Pulm]]
+
[[Category:Pulmonary]]

Latest revision as of 23:03, 10 March 2020

Background

  • Over 1/3 of world's population is infected

Infection Types

  • Primary Infection
    • Usually contained by body via formation of tubercles
    • Hematogenous spread limited to areas with high O2 or blood flow (apical lung, vertebrae)
      • PPD positive
  • Reactivation Infection
    • More common in immunocompromised patients (AIDS, malignancy, DM, immunosupressive medications)
  • Miliary Tuberculosis
    • Disseminated tuberculosis
    • Looks like millet seeds
    • Seen in patients with comorbid AIDS
      • Check HIV in patients suspected of TB
    • PPD is positive in only 50% of cases

Special Populations

  • AIDS
    • TB is 200-500x more common in AIDS population than general population
    • CD4 count
      • Increased risk when <500
      • Determines the clinical and radiographic presentations of TB
  • Pediatric
    • More likely to progress early to active disease
      • Presentation more commonly that of primary TB
    • >5yr - classic symptoms
    • <5yr - miliary TB, meningitis, cervical lymphadenitis, pneumonia that does not respond to usual antibiotics
    • Children are usually not infectious due to their weak cough

Tuberculin Skin Test

Used for population screening, but not for rule-out in patients with concern for active disease

Reaction considered positive in following situations:

  • >5 mm
    • HIV positive
    • Close contact with active TB patient
    • Nodular or fibrotic changes on CXR
    • Immunosuppressed (TNF-alpha inhibitor, chemo, organ transplant)
  • >10 mm
    • Children < 4 yrs old
    • Healthcare/lab/prison employees and residents
    • Co-morbid conditions (dialysis, DM, blood/head/neck/lung malignancy, IV drug users)
    • People from high prevalence areas
  • >15 mm
    • Persons with no known risk factors for TB

Clinical Features

Tuberculous lymphadenopathy

Primary Tuberculosis

  • Usually asymptomatic (only identified by positive PPD/quantiferon gold)
  • May be rapidly progressive and fatal in immunocompromised patients
  • Tuberculous pleural effusion may occur if subpleural node ruptures into the pleura
    • Pleuritic chest pain
    • Exudative fluid
      • Organisms may not be visible on acid-fast staining (need pleural biopsy)

Reactivation Tuberculosis

Differential Diagnosis

HIV associated conditions

Evaluation

CXR of miliary TB
Miliary TB neonate born to mother with active TB
Bilateral pulmonary tuberculosis
Tuberculous vertebral osteomyelitis (Pott's Disease)

CXR

  • Primary infection
    • Infiltrates in any area of the lung
    • Isolated hilar or mediastinal adenopathy may be only finding
  • Reactivation infection
    • cavitary/noncavitary lesions in upper lobe or superior segment of lower lobe
  • Latent infection
    • Upper lobe or hilar nodules and fibrotic lesions
    • Ghon foci, areas of scarring, calcification
  • Miliary TB
    • Looks like millet seeds on CXR
  • Immunocompromised patients less likely to have classic lesions and may have normal CXR

PCR Sputum Assay

  • Rapidly detects TB in sputum specimens (as well as rifampin resistance)
  • Use to rule-out patients for active TB
  • Need two sputum specimens (expectorated or induced) at least 8 hours apart (including at least one early morning specimen)

Management

Active TB

Latent TB

  • Isoniazid x 9 months
  • Consider treatment for:
    • Recent conversion to PPD-positive
    • close contact with active TB
    • immunocompromised patients (or plan to start immunosuppressive medications)
  • New vaccine has demonstrated effectiveness (50%) in preventing progression to active TB[2]. However, this is not yet widely available and further research is needed.

Disposition

Discharge

  • Otherwise healthy
    • Contact public health services before discharge
      • Instructions for home isolation and follow up at appropriate clinic to receive meds
    • Do not start TB meds in ED unless specifically instructed by public health

Admit

  • Ill-appearing
  • Diagnosis is uncertain
  • Patient is treatment non-adherent

References

  1. Gutteridge, David L MD, MPH, Egan, Daniel J. MD. The HIV-Infected Adult Patient in The Emergency Department: The Changing Landscape of the Disease. Emergency Medicine Practice: An Evidence-Based Approach to Emergency Medicine. Vol 18, Num 2. Feb 2016.
  2. Final analysis of a trial of M72/AS01E vaccine to prevent tuberculosis Tait DR, Hatherill M, Van Der Meeren O, et al. N Engl J Med. 2019;381(25):2429-2439.